Co-Authors
This is a "connection" page, showing publications co-authored by Jonathan Segal and Matthew Brookes.
Connection Strength
2.385
-
The impact of SARS-CoV-2 variants on IBD management. Lancet Gastroenterol Hepatol. 2021 05; 6(5):343-344.
Score: 0.934
-
Prevention of COVID-19 in patients with IBD. Lancet Gastroenterol Hepatol. 2020 07; 5(7):639-640.
Score: 0.883
-
COVID-19 vaccinations in patients with inflammatory bowel disease. Lancet Gastroenterol Hepatol. 2020 11; 5(11):965-966.
Score: 0.226
-
Letter: online search trends suggest patient concerns around immunosuppression use in inflammatory bowel disease during COVID-19 in the United Kingdom. Aliment Pharmacol Ther. 2020 Sep; 52(5):937-939.
Score: 0.225
-
Letter: risk of severe COVID-19 outcomes associated with inflammatory bowel disease medications-reassuring insights from the United Kingdom PREPARE-IBD multicentre cohort study. Aliment Pharmacol Ther. 2021 06; 53(11):1236-1240.
Score: 0.059
-
Assessment, endoscopy, and treatment in patients with acute severe ulcerative colitis during the COVID-19 pandemic (PROTECT-ASUC): a multicentre, observational, case-control study. Lancet Gastroenterol Hepatol. 2021 04; 6(4):271-281.
Score: 0.058